Market Tracker

06/27 4:22pm ET

Mast Therapeutics Inc (NYSE MKT LLC:MSTX)

0.464
Delayed Data
As of 4:00pm ET
 +0.0144 / +3.20%
Today’s Change
0.21
Today|||52-Week Range
0.60
+10.40%
Year-to-Date
7 Biotech Stocks that are Buys Right Now
Jun 17 / Zacks.com - Paid Partner Content
Mast Therapeutics (MSTX) Shares March Higher, Can It Continue?
Jun 14 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close0.45
Today’s open0.45
Day’s range0.44 - 0.48
Volume3,508,871
Average volume (3 months)2,115,045
Market cap$86.7M
Dividend yield--
Data as of 4:00pm ET, 06/27/2016

Growth & Valuation

Earnings growth (last year)-8.70%
Earnings growth (this year)+11.00%
Earnings growth (next 5 years)+57.00%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book3.08

Competitors

 Today’s
change
Today’s
% change
OHRPOHR Pharmaceutical I...-0.16-5.82%
GTXIGTX Inc-0.08-12.90%
--Innovative Pharmaceu...+0.00+3.45%
ABEOAbeona Therapeutics ...-0.12-4.69%
Data as of 4:00pm ET, 06/27/2016

Financials

Next reporting dateAugust 10, 2016
EPS forecast (this quarter)-$0.06
Annual revenue (last year)$0.00
Annual profit (last year)-$39.8M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Brian M. Culley
Chief Financial Officer, CAO &
Senior VP
Brandi L. Roberts
Corporate headquarters
San Diego, California

Forecasts